An observational, retrospective, and multicenter study describing the use of subcutaneous teicoplanin in patients presenting with staphylococcal bone and joint infections
Latest Information Update: 21 Jan 2021
At a glance
- Drugs Teicoplanin (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 21 Jan 2021 New trial record